We invite researchers in any stream to contribute to the Open Source Drug Discovery Initiative. Listed below some of the many ways you can contribute to this initiative as a researcher1) Post innovative projects online
2) Take active role in ongoing scientific projects
3) Share your negative/positive results
4) Actively participate in review process of other projects posted on OSDD
5) Contribute your spare time towards promoting OSDD 6) Organise OSDD forums in your College, School or Institute 7) Design promotional material for OSDD The list is un-ending, and we would be glad to see a collaborative effort to fight Tuberculosis by sharing of experiences and knowledge. Please feel free to contact us at info@osdd.net or anshu@osdd.net The OSDD movement aims to bring together brilliant minds from various academic and research institutes together on a common platform to solve the problem of TB.Academic and research institutions in India and abroad interested in collaborating with OSDD on TB drug discovery may contact Dr. Geetha Vani Rayasam at gvrayasam@csir.res.in
OSDD Funding Policy :
OSDD will fund appropriate scientific projects that are involved in TB research and helps OSDD in drug discovery for TB. Projects seeking funds are required to be posted on the open project space at Sysborg 2.0 portal (http://sysborg2.osdd.net).The projects need to follow the format provided on the portal. Open Peer Review All projects that are posted on Sysborg 2.0 and seek fund are subject to open peer review. Projects need to be posted online for at least 15 days to facilitate open peer review. Researchers who post the project have the freedom to rebut any comment, add or modify the projects. After the open peer review, committee of peers will look at the appropriateness of the budget proposed. If you have decided to give it a try, we would be glad that you start with joining the movement. It is pretty simple and straightforward. In addition, feel free to join the discussions at our online discussion forum.
|
Home >
Researcher
Subpages (1):
Research updates